C4 Therapeutics CFO Kendra Adams reports sale of common shares worth $122,486.5895
CCCC•C4 Therapeutics CFO Kendra Adams sold 45,173 common shares on Nov. 12, 2026, at $2.7115 per share, for a reported total of $122,486.5895.
1. Share sale
Adams directly owned 337,150 shares after the transaction.
